Abstract
Purpose
Brain tumours constitute 25% of childhood neoplasms, and half of them are in the posterior fossa. Surgery is a fundamental component of therapy, because gross total resection is associated with a higher progression-free survival. Patients with residual tumour, progression of residual tumour or disease recurrence commonly require secondary surgery. We prospectively investigated the risk of postoperative speech impairment (POSI) and cranial nerve dysfunction (CND) following primary and secondary resection for posterior cranial fossa tumours.
Methods
In the Nordic-European study of the cerebellar mutism syndrome, we prospectively included children undergoing posterior fossa tumour resection or open biopsy in one of the 26 participating European centres. Neurological status was assessed preoperatively, and surgical details were noted post-operatively. Patients were followed up 2 weeks, 2 months and 1 year postoperatively. Here, we analyse the risk of postoperative speech impairment (POSI), defined as either mutism or reduced speech, and cranial nerve dysfunction (CND) following secondary, as compared to primary, surgery.
Results
We analysed 426 children undergoing primary and 78 undergoing secondary surgery between 2014 and 2020. The incidence of POSI was significantly lower after secondary (12%) compared with primary (28%, p = 0.0084) surgery. In a multivariate analysis adjusting for tumour histology, the odds ratio for developing POSI after secondary surgery was 0.23, compared with primary surgery (95% confidence interval: 0.08–0.65, p = 0.006). The frequency of postoperative CND did not differ significantly after primary vs. secondary surgery (p = 0.21).
Conclusion
Children have a lower risk of POSI after secondary than after primary surgery for posterior fossa tumours but remain at significant risk of both POSI and CND. The present findings should be taken in account when weighing risks and benefits of secondary surgery for posterior fossa tumours.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00381-022-05464-0/MediaObjects/381_2022_5464_Fig1_HTML.png)
Similar content being viewed by others
References
Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, Dolya A, Bray F, Hesseling P, Shin HY, Stiller CA (2017) International incidence of childhood cancer, 2001–10: a population-based registry study. Lancet Oncol 18:719–731
Rickert CH, Paulus W (2001) Epidemiology of central nervous system tumors in childhood and adolescence based on the new WHO classification. Child’s nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 17:503–511
Brandão LA, Poussaint TY (2013) Pediatric brain tumors. Neuroimaging Clin N Am 23:499–525
Villarejo F, de Diego JM, de la Riva AG (2008) Prognosis of cerebellar astrocytomas in children. Childs Nerv Syst 24:203–210
Zapotocky M, Beera K, Adamski J, Laperierre N, Guger S, Janzen L, Lassaletta A, Figueiredo Nobre L, Bartels U, Tabori U, Hawkins C, Urbach S, Tsang DS, Dirks PB, Taylor MD, Bouffet E, Mabbott DJ, Ramaswamy V (2019) Survival and functional outcomes of molecularly defined childhood posterior fossa ependymoma: cure at a cost. Cancer 125:1867–1876
Dietzsch S, Placzek F, Pietschmann K, von Bueren AO, Matuschek C, Glück A, Guckenberger M, Budach V, Welzel J, Pöttgen C, Schmidberger H, Heinzelmann F, Paulsen F, Escudero MP, Schwarz R, Hornung D, Martini C, Grosu AL, Stueben G, Jablonska K, Dunst J, Stranzl-Lawatsch H, Dieckmann K, Timmermann B, Pietsch T, Warmuth-Metz M, Bison B, Kwiecien R, Benesch M, Gerber NU, Grotzer MA, Pfister SM, Clifford SC, von Hoff K, Klagges S, Rutkowski S, Kortmann RD, Mynarek M (2020) Evaluation of prognostic factors and role of participation in a randomized trial or a prospective registry in pediatric and adolescent nonmetastatic medulloblastoma — a report from the HIT 2000 trial. Adv Radiat Oncol 5:1158–1169
Merchant TE, Li C, Xiong X, Kun LE, Boop FA, Sanford RA (2009) Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. Lancet Oncol 10:258–266
Adolph JE, Fleischhack G, Mikasch R, Zeller J, Warmuth-Metz M, Bison B, Mynarek M, Rutkowski S, Schüller U, von Hoff K, Obrecht D, Pietsch T, Pfister SM, Pajtler KW, Witt O, Witt H, Kortmann RD, Timmermann B, Krauß J, Frühwald MC, Faldum A, Kwiecien R, Bode U, Tippelt S (2020) Local and systemic therapy of recurrent ependymoma in children and adolescents: short- and long-term results of the E-HIT-REZ 2005 study. Neuro Oncol
Thompson EM, Hielscher T, Bouffet E, Remke M, Luu B, Gururangan S, McLendon RE, Bigner DD, Lipp ES, Perreault S, Cho YJ, Grant G, Kim SK, Lee JY, Rao AAN, Giannini C, Li KKW, Ng HK, Yao Y, Kumabe T, Tominaga T, Grajkowska WA, Perek-Polnik M, Low DCY, Seow WT, Chang KTE, Mora J, Pollack IF, Hamilton RL, Leary S, Moore AS, Ingram WJ, Hallahan AR, Jouvet A, Fèvre-Montange M, Vasiljevic A, Faure-Conter C, Shofuda T, Kagawa N, Hashimoto N, Jabado N, Weil AG, Gayden T, Wataya T, Shalaby T, Grotzer M, Zitterbart K, Sterba J, Kren L, Hortobágyi T, Klekner A, László B, Pócza T, Hauser P, Schüller U, Jung S, Jang WY, French PJ, Kros JM, van Veelen MC, Massimi L, Leonard JR, Rubin JB, Vibhakar R, Chambless LB, Cooper MK, Thompson RC, Faria CC, Carvalho A, Nunes S, Pimentel J, Fan X, Muraszko KM, López-Aguilar E, Lyden D, Garzia L, Shih DJH, Kijima N, Schneider C, Adamski J, Northcott PA, Kool M, Jones DTW, Chan JA, Nikolic A, Garre ML, Van Meir EG, Osuka S, Olson JJ, Jahangiri A, Castro BA, Gupta N, Weiss WA, Moxon-Emre I, Mabbott DJ, Lassaletta A, Hawkins CE, Tabori U, Drake J, Kulkarni A, Dirks P, Rutka JT, Korshunov A, Pfister SM, Packer RJ, Ramaswamy V, Taylor MD (2016) Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis. Lancet Oncol 17:484–495
Patel P, Wallace D, Boop FA, Vaughn B, Robinson GW, Gajjar A, Klimo P (2019) Reoperation for medulloblastoma prior to adjuvant therapy. Neurosurgery 84:1050–1058
Mulhern RK, Palmer SL, Merchant TE, Wallace D, Kocak M, Brouwers P, Krull K, Chintagumpala M, Stargatt R, Ashley DM, Tyc VL, Kun L, Boyett J, Gajjar A (2005) Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. Am J Clin Oncol 23:5511–5519
Frič R, Due-Tønnessen BJ, Lundar T, Egge A, Kronen Krossnes B, Due-Tønnessen P, Stensvold E, Brandal P (2020) Long-term outcome of posterior fossa medulloblastoma in patients surviving more than 20 years following primary treatment in childhood. Sci Rep 10:9371
Toescu SM, Samarth G, Layard Horsfall H, Issitt R, Margetts B, Phipps KP, Jeelani NU, Thompson DNP, Aquilina K (2020) Fourth ventricle tumors in children: complications and influence of surgical approach. Journal of neurosurgery. Pediatrics pp. 1–10
Robertson PL, Muraszko KM, Holmes EJ, Sposto R, Packer RJ, Gajjar A, Dias MS, Allen JC, Children’s Oncology G, (2006) Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children’s Oncology Group. J Neurosurg 105:444–451
Catsman-Berrevoets CE, Aarsen FK (2010) The spectrum of neurobehavioural deficits in the Posterior Fossa Syndrome in children after cerebellar tumour surgery. Cortex 46:933–946
Reed-Berendt R, Phillips B, Picton S, Chumas P, Warren D, Livingston JH, Hughes E, Morrall MC (2014) Cause and outcome of cerebellar mutism: evidence from a systematic review. Childs Nerv Syst 30:375–385
Renne B, Radic J, Agrawal D, Albrecht B, Bonfield CM, Cohrs G, Davis T, Gupta A, Hebb ALO, Lamberti-Pasculli M, Knerlich-Lukoschus F, Lindsay S, McNeely PD, Pillai S, Rai HIS, Sborov KD, Vitali A, Walling S, Woerdeman P, Suryaningtyas W, Cochrane D, Singhal A, Steinbok P (2020) Cerebellar mutism after posterior fossa tumor resection in children: a multicenter international retrospective study to determine possible modifiable factors. Childs Nerv Syst 36:1159–1169
Khan RB, Sanford RA, Kun LE, Thompson SJ (2001) Morbidity of second-look surgery in pediatric central nervous system tumors. Pediatr Neurosurg 35:225–229
Chu JK, Chiarelli PA, Rea ND, Pimentel N, Flyer BE, McComb JG, Durham SR, Krieger MD (2021) Postoperative facial palsy after pediatric posterior fossa tumor resection. J Neurosurg Pediatr 1–6
Grønbæk JK, Wibroe M, Toescu S, Frič R, Thomsen BL, Møller LN, Grillner P, Gustavsson B, Mallucci C, Aquilina K, Fellows GA, Molinari E, Hjort MA, Westerholm-Ormio M, Kiudeliene R, Mudra K, Hauser P, van Baarsen K, Hoving E, Zipfel J, Nysom K, Schmiegelow K, Sehested A, Juhler M, Mathiasen R, Grønbæk JK, Wibroe M, Toescu S, Frič R, Møller LN, Grillner P, Gustavsson B, Mallucci C, Aquilina K, Molinari E, Hjort MA, Westerholm-Ormio M, Kiudeliene R, Mudra K, Hauser P, van Baarsen K, Hoving E, Zipfel J, Nysom K, Schmiegelow K, Sehested A, Juhler M, Mathiasen R, Kjærsgaard M, Bøgeskov L, Skjøth-Rasmussen J, Hauerberg Tamm J, Poulsgaard L, Gudrunardottir T, Grønbæk SK, Blichfeldt A, Raben-Levetzau FN, Thude Callesen M, Rathe M, Klokker RB, von Oettingen G, Mikkelsen T, Henriksen LT, Cortnum S, Tofting-Olesen K, Karppinen A, Solem K, Torsvik IK, Mosand A-K, Simonsen LR, Ehrstedt C, Kristiansen I, Fritzson K, Balestrand Haga L, Fagerholt HK, Stømqvist Blixt H, Sundgren H, Håkansson Y, Castor C, Nyman P, Wretman A, Nilsson P, Bjørklund A-C, Sabel M, Haij I-L, Nilsson F, Olausson H, Cummings C, Flemming J, Afolabi D, Phipps K, Kamaly I, Williams S, Jeelani N-u-O, McArthur D, Wiles E, Walker D, Cooper R, Fellows G, Hoole L, Slater K, Kandasamy J, McAndrew R, McLaughlin K, Schumann M, Avula S, Pizer B, Rutkauskiene G, Matukevicius A, van den Abbeele L, Markia B, Pálmafy B, Clausen N, Ottosen Møller KM, Thomassen H, Cappelen J, Stensvold E, Devennay I, Lønnqvist T, Nordfors K, Lähteenmäki P (2021) Postoperative speech impairment and surgical approach to posterior fossa tumours in children: a prospective European multicentre cohort study. Lancet Child Adolesc Health
Wibroe M, Cappelen J, Castor C, Clausen N, Grillner P, Gudrunardottir T, Gupta R, Gustavsson B, Heyman M, Holm S, Karppinen A, Klausen C, Lonnqvist T, Mathiasen R, Nilsson P, Nysom K, Persson K, Rask O, Schmiegelow K, Sehested A, Thomassen H, Tonning-Olsson I, Zetterqvist B, Juhler M (2017) Cerebellar mutism syndrome in children with brain tumours of the posterior fossa. BMC Cancer 17:439
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820
Zeger SL, Liang KY, Albert PS (1988) Models for longitudinal data: a generalized estimating equation approach. Biometrics 44:1049–1060
Halekoh U, Højsgaard S, Yan J (2006) The R package geepack for generalized estimating equations. J Stat Softw 15(2):1–11
Doxey D, Bruce D, Sklar F, Swift D, Shapiro K (1999) Posterior fossa syndrome: identifiable risk factors and irreversible complications. Pediatr Neurosurg 31:131–136
Catsman-Berrevoets CE, Van Dongen HR, Mulder PG, Paz y Geuze D, Paquier PF, Lequin MH, (1999) Tumour type and size are high risk factors for the syndrome of “cerebellar” mutism and subsequent dysarthria. J Neurol Neurosurg Psychiatry 67:755–757
Küpeli S, Yalçın B, Bilginer B, Akalan N, Haksal P, Büyükpamukçu M (2011) Posterior fossa syndrome after posterior fossa surgery in children with brain tumors. Pediatr Blood Cancer 56:206–210
Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, Bayer L, LaFond D, Donahue BR, Marymont MH, Muraszko K, Langston J, Sposto R (2006) Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. Am J Clin Oncol 24:4202–4208
Pols S, van Veelen MLC, Aarsen FK, Gonzalez Candel A, Catsman-Berrevoets CE (2017) Risk factors for development of postoperative cerebellar mutism syndrome in children after medulloblastoma surgery. J Neurosurg Pediatr 20:35–41
van Dongen HR, Catsman-Berrevoets CE, van Mourik M (1994) The syndrome of ‘cerebellar’ mutism and subsequent dysarthria. Neurology 44:2040–2046
Gopalakrishnan CV, Dhakoji A, Menon G, Nair S (2012) Factors predicting the need for cerebrospinal fluid diversion following posterior fossa tumor surgery in children. Pediatr Neurosurg 48:93–101
Due-Tønnessen BJ, Helseth E (2007) Management of hydrocephalus in children with posterior fossa tumors: role of tumor surgery. Pediatr Neurosurg 43:92–96
Matsushima K, Yagmurlu K, Kohno M, Rhoton AL Jr (2016) Anatomy and approaches along the cerebellar-brainstem fissures. J Neurosurg 124:248–263
Spoto GP, Press GA, Hesselink JR, Solomon M (1990) Intracranial ependymoma and subependymoma: MR manifestations. AJR Am J Roentgenol 154:837–845
Cobourn K, Marayati F, Tsering D, Ayers O, Myseros JS, Magge SN, Oluigbo CO, Keating RF (2020) Cerebellar mutism syndrome: current approaches to minimize risk for CMS. Childs Nerv Syst 36:1171–1179
Avula S, Mallucci C, Kumar R, Pizer B (2015) Posterior fossa syndrome following brain tumour resection: review of pathophysiology and a new hypothesis on its pathogenesis. Childs Nerv Syst 31:1859–1867
Werker JF, Hensch TK (2015) Critical periods in speech perception: new directions. Annu Rev Psychol 66:173–196
Molfese D, Molfese V, Espy K (1999) The predictive use of event-related potentials in language development and the treatment of language disorders. Develop Neuropsychol 16:373–377
Berardi N, Sale A, Maffei L (2015) Brain structural and functional development: genetics and experience. Dev Med Child Neurol 57(Suppl 2):4–9
Ismail FY, Fatemi A, Johnston MV (2017) Cerebral plasticity: windows of opportunity in the developing brain. Eur J Paediatr Neurol 21:23–48
Arckens L, Schweigart G, Qu Y, Wouters G, Pow DV, Vandesande F, Eysel UT, Orban GA (2000) Cooperative changes in GABA, glutamate and activity levels: the missing link in cortical plasticity. Eur J Neurosci 12:4222–4232
Bavelier D, Levi DM, Li RW, Dan Y, Hensch TK (2010) Removing brakes on adult brain plasticity: from molecular to behavioral interventions. J Neurosci 30:14964–14971
Nahmani M, Turrigiano GG (2014) Adult cortical plasticity following injury: recapitulation of critical period mechanisms? Neuroscience 283:4–16
Duffau H (2017) Hodotopy, neuroplasticity and diffuse gliomas. Neurochirurgie 63:259–265
Schlaug G, Marchina S, Norton A (2009) Evidence for plasticity in white-matter tracts of patients with chronic Broca’s aphasia undergoing intense intonation-based speech therapy. Ann N Y Acad Sci 1169:385–394
Robles SG, Gatignol P, Lehéricy S, Duffau H (2008) Long-term brain plasticity allowing a multistage surgical approach to World Health Organization Grade II gliomas in eloquent areas. J Neurosurg 109:615–624
Di Rocco C, Chieffo D, Frassanito P, Caldarelli M, Massimi L, Tamburrini G (2011) Heralding cerebellar mutism: evidence for pre-surgical language impairment as primary risk factor in posterior fossa surgery. Cerebellum (London, England) 10:551–562
Acknowledgements
We thank the entire CMS-study group who took on the inclusion and follow-up of patients.
Funding
This study was funded by The Danish Childhood Cancer Foundation, The Swedish Childhood Cancer Foundation, The Brain Tumour Charity (UK), The Danish Cancer Society, King Christian IX and Queen Louise’s anniversary grant, The Danish Capitol Regions Research Fund, Dagmar Marshall foundation and Rigshospitalet's Research Fund in support of oncology purposes and Brainstrust (SCOT). Børnecancerfonden, 2012–9, 2014–3, 2015–14, 2016–0143, 2018–3653, 2020–6732, Barncancerfonden, PR2012-0106,KP2019-0014, Brain Tumour Charity, Kræftens Bekæmpelse, R124-A7920-15-S2, King Christian IX and Queen Louise’s anniversary grant, the Danish Capitol Regions Research Fund, Dagmar Marshall Foundation,Rigshospitalet’s Research Fund in support of oncology purposes, Braintrust. All research at Great Ormond Street Hospital NHS Foundation Trust and UCL Great Ormond Street Institute of Child Health is made possible by the NIHR Great Ormond Street Hospital Biomedical Research Centre. This work is part of Childhood Oncology Network Targeting Research, Organization & Life expectancy (CONTROL) and supported by Danish Cancer Society (R-257-A14720) and the Danish Childhood Cancer Foundation (2019–5934). The funding bodies had no role in the design of the study, analyses, interpretation of the data or decision to submit results.
Author information
Authors and Affiliations
Consortia
Contributions
All authors took part in the collection of data. JKG, AS, KS, MW, RM and MJ contributed to data analysis and interpretation. JKG, ST, RF, KS, AS, RM and MJ prepared the first draft of the manuscript. All authors approved the final version of the manuscript.
Corresponding author
Ethics declarations
Ethics approval
This study was approved in Denmark by the Research Ethics Committees of the Capital Region (H-6–2014-002). The study was approved locally in all participating countries.
Conflict of interest
The authors declare no financial, personal, or other conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Grønbæk, J.K., Toescu, S., Frič, R. et al. Postoperative speech impairment and cranial nerve deficits after secondary surgery of posterior fossa tumours in childhood: a prospective European multicentre study. Childs Nerv Syst 38, 747–758 (2022). https://doi.org/10.1007/s00381-022-05464-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-022-05464-0